Navigation Links
TriReme Medical, Inc. Receives FDA 510(K) Clearance for Chocolate PTA Balloon Catheter
Date:12/21/2011

PLEASANTON, Calif., Dec. 21, 2011 /PRNewswire/ -- TriReme Medical, Inc. ("TriReme"), a leading developer of innovative devices for the treatment of complex vascular disease, announced today that it has received 510(K) clearance from the U.S. Food and Drug Administration to market its Chocolate PTA balloon catheter ("Chocolate") for the treatment of occluded peripheral arteries. Chocolate was developed in collaboration with TriReme's subsidiary, Quattro Vascular Pte Ltd in Singapore. Chocolate's novel design incorporates a constraining structure over a semi-compliant balloon to facilitate the formation of small modules ("pillows"). Through this advance mechanism of action, Chocolate minimizes shear stress and allows for uniform inflation and rapid deflation. The Chocolate "pillows" can expand locally to facilitate plaque modification and are designed to lower the strain and trauma induced on the vessel wall.

"I am very excited to be the first physician to use Chocolate PTA in the US," said Dr. Jihad Mustapha, Director of Endovascular Interventions and Research at Metro Health Hospital in Wyoming, Michigan. "We treated complex occlusions with outstanding results, no elastic recoil and no dissections which are the most feared complications in patients with Critical Limb Ischemia. This product will be a crucial tool in the battle against Critical Limb Ischemia and major amputations."

"We are pleased to receive US regulatory approval for Chocolate PTA," added Eitan Konstantino, PhD, President and CEO of TriReme. "Chocolate is a great addition to our line of proprietary peripheral PTA catheters already available in the US, Europe and Asia. We are thrilled with Dr. Mustapha's initial US experience and believe that Chocolate will provide substantial clinical benefits to patients suffering from peripheral vascular disease, both above and below the knee."

About TriReme Medical, Inc.

Based in Pleasanton, California, TriReme Medical, Inc. is a privately held medical device company dedicated to the development, manufacturing, and commercialization of next generation percutaneous devices for the treatment of complex coronary and peripheral arterial disease. The Company's novel interventional therapies are specifically designed for large, unmet clinical needs.

 


'/>"/>
SOURCE TriReme Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System
2. TriReme Medical, Inc. Receives FDA 510K Clearance for Glider(TM) PTA Balloon Catheter
3. TriReme Medical Announces $17 Million Series D Financing
4. TriReme Medical Announces Japanese Alliance
5. TriReme Medical Lines Up Asian Strategy With Key Appointment of New Board Members
6. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
7. Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield
8. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
9. China Sky One Medical, Inc. Achieves Significant Breakthrough in Research for Sudden Cardiac Death (SCD) Early Examination Kit
10. New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
11. Luminous Medical, Inc. Secures Exclusive Rights to Glucose Sensor for Its Automated Glucose Monitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... today announced that it will be participating in the ... the InterContinental Hotel in Boston, Massachusetts ... present at 11:20 a.m. Eastern Time. A ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com .  ...
(Date:4/20/2017)... 2017   ZappRx, Inc ., a digital health company ... today announced it closed $25 million in Series B funding ... based in Seattle that is part ... The Series B round included participation from SR One ... GV (formerly Google Ventures). As part of the ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
Breaking Medicine Technology:
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying to ... rapidly reject an outdated healthcare executive resume. , “If you’re a healthcare executive open ... resume and wondering if it’s as ready as you are for a new job ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... ... named the 2017 North American CAREGiverSM of the Year for her extraordinary compassion ... one of its 60,000 North American professional caregivers for the prestigious award each ...
(Date:4/27/2017)... ... 27, 2017 , ... Offering the purest product of its kind, Swissx Labs ... more potent than the market has seen before. Swissx uses proprietary strains of hemp ... patented chromatography process for extraction, to produce its CBD oil--maximizing its benefits for health ...
(Date:4/26/2017)... ... April 26, 2017 , ... Jump Technologies, Inc., ... announced it has completed a round of funding to accelerate its growth strategies. ... Black Granite Capital is a growth equity firm focused on investments in healthcare ...
(Date:4/26/2017)... , ... April 26, 2017 ... ... is thrilled to announce the ATA 2017 President’s Awards recipients, comprised of ... demonstrated superior healthcare delivery. , The ATA 2017 President’s Awards recognize ...
Breaking Medicine News(10 mins):